Synchrony Pharma was founded in 2008 with the vision of becoming a preferred partner in the development and commercialisation of generic injectable and speciality pharmaceutical products.

By 2010 Synchrony were successful in being awarded UK tenders for its portfolio of in-licensed products, something which has continued to this day. At the same time Synchrony embarked upon developing its own product dossiers.

In 2013 Synchrony’s generic injectable dossiers were being approved and sold across the globe. Today Synchrony has over 50 business partners, a global commercial platform and a diverse product development pipeline.

Recently Synchrony have commenced building a portfolio of specialty pharma products which will provide diversification and enable leverage of it’s global commercial network.



Synchrony Pharma founded


Wholesale Dealer’s License granted by MHRA. 1st injectable product in-licensed and UK NHS tenders won


Synchrony Pharma commences development of generic injectable product dossiers


Synchrony’s portfolio of generic injectable products are out licensed and sold Globally


Synchrony surpasses 4 MILLION units sold globally


Synchrony embarks on the development of a number of speciality pharmaceutical products


The first wave of speciality pharmaceuticals products filed with the authorities & Further Geographical expansion


Synchrony’s first speciality pharmaceutical products approved and launched in the UK